Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maryland for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maryland only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maryland (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Rohit Lakhanpal (NPI 1104870401)

Field	Value
Entity Type	Individual
Organization	Rohit Lakhanpal
Address	21 Crossroads Dr
City	Owings Mills
State	MD
ZIP	21117
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	May 20, 2006

Payer Source	Total Paid
Medicare	$6.1M
Medicaid	$0

Key Findings

This provider is a retina-specialist ophthalmologist with a long Medicare billing history: the NPI was enumerated on 2006-05-20 (~20 years ago), indicating multi‑decade tenure and an established clinical practice focused on retinal care. The code mix and volumes align with specialist retinal services rather than general ophthalmology or primary care.

Medicare revenue dominates this profile: lifetime Medicare revenue is $6.1M and there is no Medicaid billing on file, so the provider effectively operates as a single‑payer (Medicare) biller in the available data. Analysts should treat this as a Medicare‑centric practice when assessing payer mix or access for low‑income populations.

Revenue concentration is highly focused: the precomputed top 3 Medicare codes by revenue account for 77.5% of this provider's total Medicare revenue, signaling that a small set of services—primarily high‑cost intravitreal drug administration and related diagnostics—drive most income. This concentration implies operational dependence on these procedure/drug lines for financial performance.

Drug injection services are the primary business line: J0178 (aflibercept) alone accounts for $4M and 65.2% of the provider's Medicare revenue, and 67028 (intravitreal injection procedure) and 92014 (comprehensive established patient visit) are also top contributors. Together these codes indicate a practice model centered on frequent intravitreal pharmacologic therapy with associated ophthalmologic evaluation and retina imaging.

This provider is an exceptional national outlier on several high‑impact codes: J0178 ranks #16 of 3204 providers nationally (100th percentile, described as an "extreme outlier"), 92014 ranks #11 of 35415 providers nationally (100th percentile, "extreme outlier"), and 92134 ranks #93 of 26868 providers nationally (100th percentile, "extreme outlier"). These standings indicate volumes far above typical national peers for aflibercept administration, comprehensive established ophthalmology visits, and retinal imaging.

For other intravitreal agents and related drug codes the provider shows above‑typical but more mixed standing: 67028 ranks #69 of 4255 providers (98th percentile, "notably above typical"), J2781 ranks #27 of 490 providers (95th percentile, "typical, unremarkable"), and J2778 and J3590 sit in mid percentiles (69th and 53th respectively, "typical, unremarkable"). This suggests broad use of multiple retinal therapeutics but with particularly concentrated aflibercept utilization.

Operational implications: the combination of very high J0178 volume and top national percentiles on retinal imaging and comprehensive visits suggests a high‑throughput, procedure‑driven retina center where frequent follow‑up and imaging support recurring intravitreal therapy regimens. Revenue planning, supply chain, and payer contract negotiations should focus on injectable biologics and imaging reimbursement dynamics.

Competitive positioning: nationally, the provider is a major outlier and high-volume supplier for key retina codes, indicating market leadership in administering aflibercept and performing associated retinal imaging. However, absence of Medicaid billing means the provider’s competitive footprint is limited in the Medicaid population and may not reflect access or market share among non‑Medicare patient segments.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	5,760	$690	$4M
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	4,340	$100	$420.7K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	3,310	$100	$327.3K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	2,120	$120	$253.9K
J3490	Unclassified drugs	130	$1,770	$233.4K
J2778	Injection, ranibizumab, 0.1 mg	1,170	$190	$220K
J3590	Unclassified biologics	90	$2,300	$216.2K
J2777	Injection, faricimab‑svoa, 0.1 mg	5,220	$30	$151.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	4,380	$30	$148.9K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	190	$220	$40.6K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maryland Distribution

Rohit Lakhanpal — 6 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maryland

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	1	100	950	$690	$887.3K
J2777	45	70	8,520	$30	$487.3K
J2781	3	20	620	$120	$258.6K
J2778	18	50	650	$180	$207.8K
J3590	4	20	50	$2,390	$128.9K
67028	3	120	700	$100	$101.5K
Q5128	11	20	200	$210	$78K
J3490	26	100	70	$450	$62.1K
92014	2	620	210	$90	$44K
92134	6	490	110	$30	$17.3K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with Rohit Lakhanpal, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Associated Retinal Consultants LLC	DE	Ophthalmology Physician	$0	$25.2M
The Retina Group Of Washington, PLLC	MD	Ophthalmology Physician	$0	$19.5M
Virginia Oncology Associates	VA	Hematology & Oncology Physician	$0	$6.2M
Gordon Byrnes	VA	Retina Specialist (Ophthalmology) Physician	$4.9M	$0
Daniel Berinstein	MD	Retina Specialist (Ophthalmology) Physician	$4.3M	$0
Alexander Melamud	VA	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Michael Lai	MD	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Jordana Fein	VA	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Vinod Voleti	NJ	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Eric Weichel	MD	Ophthalmology Physician	$4.1M	$0

Nearby Providers

Other providers in the same ZIP code as Rohit Lakhanpal, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Advanced Radiology P A	MD	Diagnostic Radiology Physician	$0	$41.4M
Maximum Day Services, LLC	MD	Adult Day Care Clinic/Center	$0	$19.1M
Lifeway Adult Medical Day Center, LLC	MD	Adult Day Care Clinic/Center	$0	$15.7M
Maximum Day Services Ii, LLC	MD	Adult Day Care Clinic/Center	$0	$13.5M
All Staffing, Inc.	MD	Home Health Agency	$0	$12.6M
Adult Day Health, Inc.	MD	Adult Day Care Clinic/Center	$0	$12.4M
Progress Unlimited Medical Adult Day Program And Wellness Center	MD	Adult Day Care Clinic/Center	$0	$11.1M
Gaudenzia Inc	MD	Substance Use Disorder Rehabilitation Clinic/Center	$0	$9.3M
Advanced Pain Management Specialists, LLC	MD	Clinical Medical Laboratory	$0	$8.8M
Patient First Maryland Medical Group PLLC	MD	Family Medicine Physician	$0	$8.7M

Rohit Lakhanpal — Billing Profile & Reimbursement Data

Sign up for Rohit Lakhanpal — Billing Profile & Reimbursement Data policy alerts

Rohit Lakhanpal — Billing Profile & Reimbursement Data

Sign up for Rohit Lakhanpal — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References